Literature DB >> 10837455

PER-1 beta-lactamase-producing Pseudomonas aeruginosa in an intensive care unit.

G Claeys, G Verschraegen, T de Baere, M Vaneechoutte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10837455     DOI： 10.1093/jac/45.6.924

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  13 in total

Review 1.  Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact.

Authors:  Gerhard F Weldhagen; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Biochemical characterization of PER-2 and genetic environment of blaPER-2.

Authors:  Pablo Power; José Di Conza; María Margarita Rodríguez; Bárbara Ghiglione; Juan A Ayala; José María Casellas; Marcela Radice; Gabriel Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

3.  Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.

Authors:  F Luzzaro; E Mantengoli; M Perilli; G Lombardi; V Orlandi; A Orsatti; G Amicosante; G M Rossolini; A Toniolo
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria.

Authors:  Laurent Poirel; Ludovic Cabanne; Haluk Vahaboglu; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 5.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

6.  Phenotypic and Genetic Characterization of Carbapenemase and ESBLs Producing Gram-negative Bacteria (GNB) Isolated from Patients with Cystic Fibrosis (CF) in Tehran Hospitals.

Authors:  Parisa Vali; Fereshteh Shahcheraghi; Maryam Seyfipour; Maryam Alsadat Zamani; Mohammad Reza Allahyar; Mohammad Mehdi Feizabadi
Journal:  J Clin Diagn Res       Date:  2014-01-12

7.  Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex.

Authors:  Joanna Empel; Krzysztof Filczak; Agnieszka Mrówka; Waleria Hryniewicz; David M Livermore; Marek Gniadkowski
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

8.  Evaluation of the Osiris expert system for identification of beta-lactam phenotypes in isolates of Pseudomonas aeruginosa.

Authors:  Frédéric Bert; Zahia Ould-Hocine; Manette Juvin; Véronique Dubois; Véronique Loncle-Provot; Valérie Lefranc; Claudine Quentin; Nicole Lambert; Guillaume Arlet
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

9.  Investigation of the Antimicrobial Susceptibility Profile, Virulence Genes, and Epidemiologic Relationship of Clinical Salmonella Isolates.

Authors:  Yamaç Tekintaş; Fethiye Ferda Yilmaz; Sabire Şöhret Aydemir; Alper Tünger; Mine Hoşgör-Limoncu
Journal:  Turk J Pharm Sci       Date:  2018-07-17

10.  Molecular epidemiology of PER-1 extended spectrum beta-lactamase among gram-negative bacteria isolated at a tertiary care hospital.

Authors:  B Eraç; Z Gülay
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.